VIROGATES A/S : announces initiation of a clinical trial with HISS to clinically validate its commercial biomarker test for guiding early anakinra treatment of COVID-19 patients across 42 hospitals
MarketScreener,
suPARnostic® can become the first companion diagnostic device to aid in selecting and excluding COVID-19 patient groups for…